Business
Aeglea BioTherapeutics to Participate in Upcoming September Conference
WALTHAM, Mass., Sept. 14, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of
About this update from Spyre Therapeutics, Inc.
[{"type":"text","content":"WALTHAM, Mass., Sept. 14, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (\"Aeglea\") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease (\"IBD\"), today announced that management will participate in the Stifel 2023 Immunology & Inflammation Virtual Summit.\n\n \n \n \n \n \n \n\n \nChief Operating Officer Cameron Turtle, DPhil, will be speaking at a fireside chat amongst leading public and private biotech companies in the Immunology and Inflammation space on Wednesday, September 20, 2023 from 11:00 am to 11:45 am Eastern Standard Time. Online streaming of the chat will be available.\nParticipants can view the webcast through the following link: https://wsw.com/webcast/stifel82/agle/2058441\nAbout Aeglea BioTherapeuticsIn June 2023, Aeglea completed the asset acquisition of Spyre Therapeutics, Inc. and shifted its disease focus to IBD. Aeglea is advancing a pipeline of antibody therapeutics with the potential to transform the treatment of IBD. The approaches combine novel antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD. The company's portfolio includes potentially best-in-class antibodies targeting α4β7, TL1A, and IL-23.\nForward-Looking StatementsCertain statements in the fireside chat, other than purely historical information, may constitute \"forward-looking statements\" within the meaning of the federal securities laws, including for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995, concerning Aeglea and other matters. These forward-looking statements include, but are not limited to, express or implied statements relating to Aeglea's management team's expectations, hopes, beliefs, intentions or strategies regarding the future including, without limitation, Aeglea's business plans and the anticipated benefits of the management changes. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words \"opportunity,\" \"potential,\" \"milestones,\" \"pipeline,\" \"can,\" \"goal,\" \"aim,\" \"strategy,\" ...